DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 2.03% to $187.57 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 45,216.14 and the S&P 500 Index falling 0.39% to 6,343.72.
Biogen Inc. closed 7.33% below its 52-week high of $202.41, which the company reached on February 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.85% to $242.49, Pfizer Inc. $(PFE)$ rose 2.70% to $27.77, and AbbVie Inc. $(ABBV)$ rose 1.78% to $213.12.
Trading volume (799,100) remained 414,536 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 30, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments